ONCT - Oncternal Therapeutics Inc
IEX Last Trade
4.27
0.160 3.747%
Share volume: 3,096
Last Updated: Fri 30 Aug 2024 09:57:48 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.11
0.16
3.89%
Summary score
24%
Profitability
25%
Dept financing
4%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-19.93%
Return on assets
-16.2%
Return on sales
-3025.52%
Return on invested capital
160.68%
Total debt ratio
13.82%
Debt ratio change over timeo
-0.87%
Current Ratio
11.46%
Quick Ratio
11.46%
Cash Position Ratio
11.04%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-28.4%
Return on assets
-24.8%
Return on sales
-4899.13%
Return on invested capital
198.52%
Total debt ratio
16.22%
Debt ratio change over timeo
-0.92%
Current Ratio
7.55%
Quick Ratio
7.55%
Cash Position Ratio
7.06%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-36.59%
Return on assets
-30.13%
Return on sales
-1542.88%
Return on invested capital
153.09%
Total debt ratio
21.33%
Debt ratio change over time
-0.89%
Current Ratio
4.66%
Quick Ratio
4.66%
Cash Position Ratio
4.42%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-116.75%
Return on assets
-112.15%
Return on sales
-1809.95%
Return on invested capital
-2.72%
Total debt ratio
-86.55%
Debt ratio change over time
-0.87%
Current Ratio
5.65%
Quick Ratio
5.65%
Cash Position Ratio
5.4%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ONCT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -19.93% | 13.79% | 34.47% | 7.43% |
| Return on assets | -16.2% | 2.76% | 3.15% | 5.62% |
| Return on sales | -3025.52% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 160.68% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 58% |
| Total debt ratio | 13.82% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.87% | 308.97% | -6.99% | 1.18% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 7.55% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 7.55% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 7.06% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 10% | 23% |
| Short-term ratios | ONCT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -28.4% | 13.77% | 13.25% | 3.8% |
| Return on assets | -24.8% | 2.43% | 1.89% | 3.09% |
| Return on sales | -4899.13% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 198.52% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 16.22% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.92% | 46.38% | -72.08% | 1.51% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 7.55% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 7.55% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 7.06% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 18% | 44% |